REACHing forward—a strategic vision for ECCO and the future of IBD care

By
Britta Siegmund
Ailsa Hart
February 14, 2026
0 min

Journal Of Crohn's And Colitis

Objective:

To outline ECCO's R E A C H strategy for improving care, research, and advocacy in inflammatory bowel disease (IBD) over the next five years.

Key Findings:

Rapid diagnosis and treatment are crucial for altering disease trajectories.
Equitable access to care is essential as IBD becomes a global health concern.
Sustainability in healthcare systems is necessary to meet future demands.
Research into the causes of IBD is advancing rapidly.
Holistic care must include multidisciplinary support for patients.

Interpretation:

The R E A C H strategy represents a comprehensive approach to addressing the multifaceted challenges in IBD care, emphasizing the need for timely, equitable, sustainable, and holistic treatment.

Limitations:

The strategy's effectiveness will depend on global collaboration and implementation.
Challenges in achieving equitable access may persist in various regions.

Conclusion:

R E A C H is ECCO's strategic commitment to redefine IBD care standards from 2024 to 2028, aiming for a future that is scientifically advanced, equitable, sustainable, and human-centered.

REACHing forward—a strategic vision for ECCO and the future of IBD care

Objective:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

REACHing forward—a strategic vision for ECCO and the future of IBD care

Related Content

Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections

Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort study

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push